- Country: United Kingdom
- Summary: NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025
- GBT Ref No: 116660374
- Deadline: 11 Apr 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: GBP 1819623796
- Notice Type: Tender
- Document Ref. No.:
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Provision of Medical Retinal Vascular Anti Veg-F and Intravitreal Corticosteroid medicines used in medical retinal vascular services for the NHS in England. To include but not limited to aflibercept, bevacizumab, brolucizumab, intravitreal dexamethasone, intravitreal fluocinolone, faricimab and ranibizumab used in the treatment of; • neovascular (wet) age-related macular degeneration (AMD) • visual impairment due to macular oedema secondary to retinal vein occlusion (branch RVO or central RVO) • proliferative diabetic retinopathy (PDR) • visual impairment due to diabetic macular oedema (DME) • visual impairment due to diabetic macular oedema (DME) who are pseudophakic or who are considered insufficiently responsive to, or unsuitable for non-corticosteroid therapy • vision impairment associated with chronic diabetic macular oedema, (DME) • visual impairment due to myopic choroidal neovascularisation (myopic CNV) • retinopathy of prematurity (ROP) with zone I (stage 1+, 2+, 3 or 3+), zone II (stage 2+ or 3+) or AP-ROP (aggressive posterior ROP) disease • inflammation of the posterior segment of the eye presenting as non-infectious uveitis • prevention of relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye
Notice identifier : 2025/S 000-010548
CPV classifications: 33600000 - Pharmaceutical products33690000 - Various medicinal products - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINNHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025 - Greatbritain Tender
The NHS ENGLAND, a Government sector organization in United Kingdom, has announced a new tender for NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025. This tender is published on GreatbritainTenders under GBT Ref No: 116660374 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-04-11.
The estimated tender value is GBP 1819623796, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
